About
Admatrone is an advanced anti-androgen agent primarily utilized in the management of metastatic castration-resistant prostate cancer (mCRPC). Its mechanism of action involves potent and selective inhibition of cytochrome P450 17α-hydroxylase (CYP17), a key enzyme expressed in testicular, adrenal, and prostatic tumor tissues. CYP17 is essential for the biosynthesis of androgens, which are hormones that fuel the growth of prostate cancer cells. By effectively blocking androgen production at multiple sites, Admatrone significantly reduces the levels of circulating androgens, thereby suppressing the proliferation of hormone-sensitive prostate cancer cells. This targeted hormonal therapy represents a crucial advancement in extending survival and improving outcomes for patients whose disease has progressed despite conventional androgen deprivation therapy. It is typically administered orally and is often prescribed in combination with a corticosteroid, such as prednisone or prednisolone, to mitigate potential mineralocorticoid excess side effects.
Uses
- Treatment of metastatic castration-resistant prostate cancer.
- Inhibition of androgen production.
- Management of hormone-sensitive prostate cancer.
- Used in combination with corticosteroids.
Directions For Use
Take orally once daily on an empty stomach, at least one hour before or two hours after food. Swallow tablets whole.
Benefits
- Extends overall survival in prostate cancer.
- Reduces prostate-specific antigen (PSA) levels.
- Effective in castration-resistant disease.
- Oral administration.
- Targets androgen synthesis pathways.
- Improves quality of life for patients.
Side Effects
- Fatigue
- Joint swelling or discomfort
- Hot flashes
- Diarrhea
- Nausea
- Vomiting
- Hypertension
- Hypokalemia (low potassium)
- Fluid retention (edema)
- Elevated liver enzymes
- Urinary tract infection
- Anemia
Safety Measures
- Alcohol - Limit alcohol intake as it may contribute to liver strain, which is a potential side effect of Admatrone.
- Pregnancy - Admatrone is contraindicated in pregnant women due as it can cause fetal harm. Women of childbearing potential should avoid contact with crushed or broken tablets.
- Breastfeeding - It is unknown if Admatrone is excreted in human milk. Due to the potential for serious adverse reactions in breastfed infants, breastfeeding is not recommended.
- Liver - Use with caution in patients with pre-existing liver impairment. Liver function tests should be monitored closely, and dose adjustments or discontinuation may be necessary.
- Kidney - No specific dose adjustment is typically required for mild to moderate renal impairment, but caution is advised in severe cases.
- Lung - No specific lung-related safety notes are typically highlighted for this class of medication. However, general monitoring for new respiratory symptoms is always prudent.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!